Hunter Robert Merrill 4
4 · CALLISTO PHARMACEUTICALS INC · Filed Jan 22, 2013
Insider Transaction Report
Form 4
Hunter Robert Merrill
10% Owner
Transactions
- Disposition to Issuer
Common Stock
2013-01-17−21,891,922→ 0 total
Footnotes (1)
- [F1]Pursuant to the Agreement and Plan of Merger, dated as of July 20, 2012, as amended October 15, 2012, by and between Synergy Pharmaceuticals Inc ("Synergy") and Callisto Pharmaceuticals, Inc. ("Callisto"), Callisto merged with and into Synergy (the "Merger"). Upon the effective time of the Merger, each share of Callisto common stock was cancelled and exchanged for .1799 shares of Synergy common stock (the "Exchange Ratio").